Form EFFECT Indaptus Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 31, 2024 4:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Multispectral Vision and Edge AI Drive Solid Post-IPO Momentum for HQVT (01392.HK)
- Airtripmaker is expanding its business class and First Class flight travel to Australia, Africa, Japan, Europe, Dubai, India, Asia by introducing enhanced coverage for global destinations as part of i
- New Mermaid Short: Hessian Soldier Haunted at Sea by a Rhine Siren
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
